Mary Norton is a professor in the Maternal Fetal Medicine Division of the Department of Obstetrics, Gynecology and Reproductive Sciences. She earned her BA in zoology and Russian at the University of Washington, and also earned her Medical Degree at UW. She completed her Ob/Gyn residency at Tufts University in Boston and then went on to complete her fellowship in Maternal Fetal Medicine and Clinical Genetics at UCSF. She is board-certified in Obstetrics and Gynecology and Maternal Fetal Medicine, as well as in Clinical Genetics. She is currently Vice Chair of Clinical and Translational Genetics and Director of the Prenatal Genetic Screening Program at the University of California, San Francisco. She is also presently the interim co-division chief of the medical genetics division in the Department of Pediatrics. She is interested in public policy and public health surrounding prenatal genetic testing programs, and is a member of the Perinatal Advisory Committee for the California State Genetic Disease Screening Program. Her research interests include genetic testing and its application to prenatal screening and diagnosis. She focuses on the unique aspects of translating new technologies into improved care for pregnant women and their fetuses. She is currently involved in projects that include mechanisms and disorders associated with nonimmune hydrops fetalis and potential for in utero therapy, and application of whole exome and genome sequencing in the prenatal context. Her other research and clinical interests involve prenatal genetic screening and diagnostic testing, obstetrical ultrasound, fetal therapy, and patient preferences and decision-making.

Bo Jacobsson is Professor in Obstetrics and Gynecology at Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden and senior researcher at Norwegian Institute of Public Health, Oslo, Norway He is presently director of the Perinatal Research Laboratory and Fetal Medicine Department at Sahlgrenska University Hospital in Gothenburg, Sweden where he also does his clinical obstetrical and fetal medicine practice. He is also associated with the Norwegian Institute of Public Health. Prof. Jacobsson’s research groups are located in Gothenburg, Sweden and Oslo, Norway. He is studying basic and applied aspects of the mechanisms of preterm delivery and genetics in complex disease. Another area that has attracted his interest is genetic components of the timing of delivery and also the interplay between genes and the environment. One of his main interests for the moment is the possibility to prevent preterm delivery to happen by intervention with dietary products, e.g. probiotics. The main research aim is to identify and apply different strategies to prevent preterm delivery to increase the outcome of healthy children. He has also studied infections during pregnancy and pregnancy and child outcome. Prof. Jacobsson has published more than 140 per reviewed papers between 2002 and 2014, and has been invited to lecture and activelly paticipate in more than 50 international scientific conferences. Prof Jacobsson has a track record of beeing involved in all levels of education since 20 years. He has had the main responsibility for undergraduate medcial education in Obstetrics and Gynecology at Sahlgrenska Academy since 2007. Since 2009 he is responsible for teaching of medical doctors in Obstetctrics and Gynecology with exames outside the European Community.

Dr. Thomas Musci graduated cum laude from Georgetown University School of Medicine in Washington, DC, and then continued his medical training at the University of California, San Francisco, by completing an internship and a residency in obstetrics and gynecology; fellowships in maternal-fetal medicine, cardiovascular research, and medical genetics; and postdoctoral research with Marc Kirschner, PhD, in the department of biochemistry and biophysics. He is board certified in obstetrics and gynecology, maternal-fetal medicine, and medical genetics. Currently, Dr. Musci serves as Chief Medical Officer at Ariosa Diagnostics, where he has been since 2012. He held past positions in the maternal-fetal medicine program at the California Pacific Medical Center in San Francisco, and as Associate Clinical Professor at the University of California School of Medicine, and as Director of Clinical Affairs, Predictive Health at Novartis Diagnostics, Inc. He served as the past chair of the Committee on Genetics for the American Congress of Obstetricians and Gynecologists (ACOG), and as a member of the Professional Practice Guidelines Committee for the American College of Medical Genetics (ACMG). Dr. Musci is on the editorial advisory board of the American Journal of Obstetrics and Gynecology and is an ad hoc peer reviewer of several professional publications, such as the Journal of Maternal-Fetal Medicine, Obstetrics and Gynecology, Placenta, Prenatal Diagnosis, and Journal of Maternal Fetal and Neonatal Medicine. In addition, he has authored and co-authored many publications on topics including cell-free DNA technology, preeclampsia, fibroblast growth factor, FISH, gene expression, and prenatal screening.